Your browser doesn't support javascript.
Maternal and neonatal outcomes of COVID-19 in a high-risk pregnant cohort with and without HIV.
De Waard, L; Langenegger, E; Erasmus, K; Van der Merwe, T; Olivier, S E; Du Toit, N; Paulsen, C; Nkangana, N; Van Niekerk, M; Moodley, A; Schell, S; Taljaard, J; Botha, M H; Dramowski, A; Cluver, C A; Bekker, A.
  • De Waard L; Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. ldewaard@sun.ac.za.
S Afr Med J ; 111(12): 1174-1180, 2021 12 02.
Article in English | MEDLINE | ID: covidwho-1561763
ABSTRACT

BACKGROUND:

The impact of SARS-CoV-2 infection in pregnant women living with HIV (PLHIV) has not been described previously.

OBJECTIVES:

To describe the clinical presentation and outcomes of a cohort of women with high-risk pregnancies with confirmed COVID-19 to determine whether risk factors for disease severity and adverse outcomes of COVID-19 differed in pregnant women without HIV compared with PLHIV.

METHODS:

We prospectively enrolled pregnant women with COVID-19 attending the high-risk obstetric service at Tygerberg Hospital, Cape Town, South Africa, from 1 May to 31 July 2020, with follow-up until 31 October 2020. Women were considered high risk if they required specialist care for maternal, neonatal and/or anaesthetic conditions. Common maternal or obstetric conditions included hypertensive disorders, morbid obesity (body mass index (BMI) ≥40 kg/m2) and diabetes. Information on demographics, clinical features, and maternal and neonatal outcomes was collected and compared for PLHIV v. pregnant women without HIV.

RESULTS:

One hundred women (72 without HIV and 28 PLHIV) with high-risk pregnancies had laboratory-confirmed COVID-19. Among the 28 PLHIV, the median (interquartile range) CD4 count was 441 (317 - 603) cells/µL, and 19/26 (73%) were virologically suppressed. COVID-19 was diagnosed predominantly in the third trimester (81%). Obesity (BMI ≥30 in n=61/81; 75%) and hypertensive disorders were frequent comorbidities. Of the 100 women, 40% developed severe or critical COVID-19, 15% required intensive care unit admission and 6% needed invasive ventilation. Eight women died, 1 from advanced HIV disease complicated by bacteraemia and urosepsis. The crude maternal mortality rate was substantially higher in women with COVID-19 compared with all other deliveries at our institution during this period (8/91 (9%) v. 7/4 058 (0.2%); p<0.001). Neonatal outcomes were favourable. No significant differences in COVID-19 risk factors, disease severity, and maternal/neonatal outcome were noted for PLHIV v. those without HIV.

CONCLUSIONS:

In this cohort of high-risk pregnant women, the impact of COVID-19 was severe, significantly increasing maternal mortality risk compared with baseline rates. Virally suppressed HIV infection was not associated with worse COVID-19 outcomes in pregnancy.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnancy Complications, Infectious / Pregnancy Outcome / HIV Infections / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Infant, Newborn / Pregnancy Country/Region as subject: Africa Language: English Journal: S Afr Med J Year: 2021 Document Type: Article Affiliation country: SAMJ.2021.v111i12.15683

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnancy Complications, Infectious / Pregnancy Outcome / HIV Infections / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Infant, Newborn / Pregnancy Country/Region as subject: Africa Language: English Journal: S Afr Med J Year: 2021 Document Type: Article Affiliation country: SAMJ.2021.v111i12.15683